Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
24.03
+0.04 (0.17%)
Nov 12, 2025, 9:45 AM EST - Market open
Fresenius Medical Care AG Employees
Fresenius Medical Care AG had 111,513 employees as of December 31, 2024. The number of employees decreased by 8,332 or -6.95% compared to the previous year.
Employees
111,513
Change (1Y)
-8,332
Growth (1Y)
-6.95%
Revenue / Employee
$206,674
Profits / Employee
$7,556
Market Cap
13.93B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 111,513 | -8,332 | -6.95% |
| Dec 31, 2023 | 119,845 | -8,199 | -6.40% |
| Dec 31, 2022 | 128,044 | 5,135 | 4.18% |
| Dec 31, 2021 | 122,909 | -2,455 | -1.96% |
| Dec 31, 2020 | 125,364 | 4,705 | 3.90% |
| Dec 31, 2019 | 120,659 | 8,001 | 7.10% |
| Dec 31, 2018 | 112,658 | -1,342 | -1.18% |
| Dec 31, 2017 | 114,000 | 4,681 | 4.28% |
| Dec 31, 2016 | 109,319 | 5,286 | 5.08% |
| Dec 31, 2015 | 104,033 | 4,138 | 4.14% |
| Dec 31, 2014 | 99,895 | 9,205 | 10.15% |
| Dec 31, 2013 | 90,690 | 4,537 | 5.27% |
| Dec 31, 2012 | 86,153 | 6,994 | 8.84% |
| Dec 31, 2011 | 79,159 | 5,707 | 7.77% |
| Dec 31, 2010 | 73,452 | 5,464 | 8.04% |
| Dec 31, 2009 | 67,988 | 3,322 | 5.14% |
| Dec 31, 2008 | 64,666 | 3,260 | 5.31% |
| Dec 31, 2007 | 61,406 | 4,603 | 8.10% |
| Dec 31, 2006 | 56,803 | 9,282 | 19.53% |
| Dec 31, 2005 | 47,521 | 2,995 | 6.73% |
| Dec 31, 2004 | 44,526 | 3,429 | 8.34% |
| Dec 31, 2003 | 41,097 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
FMS News
- 7 days ago - Fresenius Medical Care AG (FMS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025 - PRNewsWire
- 8 days ago - Fresenius Medical Care beats quarterly profit estimates helped by cost cuts - Reuters
- 13 days ago - Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025 - PRNewsWire
- 6 weeks ago - Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement - PRNewsWire
- 7 weeks ago - Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment - PRNewsWire
- 3 months ago - Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - PRNewsWire
- 3 months ago - Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript - Seeking Alpha